CD123, Human (Talacotuzumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.

Search, find, compare suppliers for anti-CD123, Human (Talacotuzumab biosimilar) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityCD123, Human (Talacotuzumab biosimilar)
CloneTalacotuzumab
Host SpeciesRecombinant
Reactive Specieshuman
IsotypeIgG2 kappa
Formatpurified
Size1mg, 5mg
Concentration1mg/ml
Applicationsn/a
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionAnti-Human CD123 Recombinant Antibody (Talacotuzumab). Zolbetuximab (development code IMAB362) is an experimental monoclonal antibody against isoform 2 of Claudin-18. It is under investigation for the treatment of gastrointestinal adenocarcinomas and pancreatic tumors. IMAB362 was developed by Ganymed Pharmaceuticals AG. The drug is in phase II clinical trials as of January 2013.
Immunogenn/a
Other NamesAnti-CD123 Recombinant Antibody, Research Grade Talacotuzumab, Anti-Human CD123 Recombinant Antibody(Talacotuzumab), CSL-362-AML, CSL362, JNJ-56022473, Antibody Drug Analogues, Monoclonal Antibody, YR1468, Research Grade Biosimilars, Biosimilar Antibody
Gene, Accession #CAS: 1826831-79-1
Catalog #YR1468
Priceplease inquire
Order / More InfoCD123, Human (Talacotuzumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.
Product Specific Referencesn/a
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
FL-4, Building A5
International Enterprise Community
Tianjin CHINA
P: 400-621-6806

info@kmdbioscience.com
Sales: sales@kmdbiosci.com

https://www.kmdbioscience.com

Profile of KMD BIOSCIENCE CO. LTD.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.